chartexchange

PBE
Invesco Biotechnology & Genome ETF
stockNYSEETF

Market OpenNov 19, 2026 1:48:04 PM EST
94.82USD-1.177%(-1.13)4,984
93.77Bid94.50Ask0.73Spread
Loading…
Loading…
415.67M
HQ
IL, USA
Previous Close
$95.95
Beta
0.73
52-Week High
$104.69 2026-11-04
52-Week Low
$75.50 2026-03-27
SMA 50
$97.51
SMA 200
$88.32
Avg. Vol 10D
23,539
Avg. Vol 30D
18,432
Avg. Vol 90D
25,552
Relative Vol
0.27
4.40M
2.6400%
4,997
Sep 24, 2018 · $0.002
PBE Profile

The investment seeks to track the investment results (before fees and expenses) of the Dynamic Biotech & Genome IntellidexSM Index. The fund generally will invest at least 90% of its total assets in common stocks of biotechnology companies and genome companies that comprise the underlying intellidex. The underlying intellidex was composed of common stocks of 30 U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.

PBE Performance
PeriodPriceDateChangeBeta
1W98.432026-11-12-4.02%1.197
1M96.712026-10-19-2.31%1.052
3M98.262026-08-19-3.86%1.024
6M80.482026-05-19+17.39%0.650
1Y77.902025-11-19+21.27%0.734
2Y66.592024-11-19+41.87%—
5Y73.392021-11-19+28.73%0.842
PBE Stock Summary

Invesco Biotechnology & Genome ETF (NYSE:PBE) stock price today is $94.47, and today's volume is 4,956. PBE is down 1.542% today. The 30 day average volume is 18,432. PBE market cap is $415.67M with 4.40M shares outstanding.